Early origins of heart disease: Low birth weight and the role of the insulin-like growth factor system in cardiac hypertrophy

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 11, 2012, Pages 958-964

  Wang, Kimberley Cw ^a   Botting, Kimberley J ^a,c   Padhee, Monalisa ^a   Zhang, Song ^a   Mcmillen, I Caroline ^a   Suter, Catherine M ^d   Brooks, Doug A ^b   Morrison, Janna L ^a  

^a Early Origins of Adult Health Research Group   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

Author keywords

Epigenetics; Hypertrophy; Insulin like growth factors; Intrauterine growth restriction

Indexed keywords

CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PROTEIN KINASE C; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

APOPTOSIS; ARTICLE; BIRTH WEIGHT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DNA MODIFICATION; EPIDEMIOLOGICAL DATA; EPIGENETICS; FETUS DEVELOPMENT; GENE EXPRESSION; HEART DEVELOPMENT; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPOXEMIA; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; NONHUMAN; PATHOPHYSIOLOGY; POSTNATAL DEVELOPMENT; PRENATAL GROWTH; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; HEART DISEASES; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; RECEPTOR, IGF TYPE 2; SOMATOMEDINS;

EID: 84868151941     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05743.x     Document Type: Article

References (117)

1. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy. Experimental findings and therapeutic strategies. Pharmacol. Ther. 2010; 128: 191-227.
2. Adams JW, Sakata Y, Davis MG et al. Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl Acad. Sci. USA 1998; 95: 10140-5.
3. Lorell BH, Carabello BA. Left ventricular hypertrophy. Pathogenesis, detection, and prognosis. Circulation 2000; 102: 470-9.
4. Knöll R, Iaccarino G, Tarone G et al. Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: A position paper of the Working Group 'Myocardial Function' of the ESC. Eur. J. Heart Fail. 2011; 13: 811-19.
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 1990; 322: 1561-6.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann. Intern. Med. 1989; 110: 101-7.
7. Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am. Heart J. 2000; 140: 848-56.
8. Kannel WB. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur. Heart J. 1992; 13: 82-8.
9. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. The Framingham Heart Study. Ann. Intern. Med. 1988; 108: 7-13.
10. Liao Y, Cooper RS, Mensah GA, McGee DL. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995; 92: 805-10.
11. Iacobellis G, Pond C, Sharma A. Different 'weight' of cardiac and general adiposity in predicting left ventricle morphology. Obesity 2006; 14: 1679-84.
12. Gardin JM, Lauer MS. Left ventricular hypertrophy: The next treatable, silent killer? JAMA 2004; 292: 2396-8.
13. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: The Framingham Heart Study. J. Am. Coll. Cardiol. 1991; 18: 1287-94.
14. Leipälä JA, Boldt T, Turpeinen U, Vuolteenaho O, Fellman V. Cardiac hypertrophy and altered hemodynamic adaptation in growth-restricted preterm infants. Pediatr. Res. 2003; 53: 989-93.
15. Vijayakumar M, Fall CH, Osmond C, Barker DJ. Birth weight, weight at one year, and left ventricular mass in adult life. Br. Heart J. 1995; 73: 363-7.
16. Battista MC, Calvo E, Chorvatova A, Comte B, Corbeil J, Brochu M. Intrauterine growth restriction and the programming of left ventricular remodelling in female rats. J. Physiol. 2005; 565: 197-205.
17. Veille JC, Hanson R, Sivakoff M, Hoen H, Ben-Ami M. Fetal cardiac size in normal, intrauterine growth retarded, and diabetic pregnancies. Am. J. Perinatol. 1993; 10: 275-9.
18. Wang KC, Zhang L, McMillen IC et al. Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb. J. Physiol. 2011; 589: 4709-22.
19. Greenwood PL, Hunt AS, Bell AW. Effects of birth weight and postnatal nutrition on neonatal sheep. IV. Organ growth. J. Anim. Sci. 2004; 82: 422-8.
20. Rueda-Clausen CF, Morton JS, Davidge ST. Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc. Res. 2009; 81: 713-22.
21. Cetin I, Foidart JM, Miozzo M et al. Fetal growth restriction: A workshop report. Placenta 2004; 25: 753-7.
22. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome. Prediction, plasticity, and programming. Physiol. Rev. 2005; 85: 571-633.
23. Peleg D, Kennedy CM, Hunter SK. Intrauterine growth restriction: Identification and management. Am. Fam. Physician 1998; 58: 453-60.
24. Vandenbosche RC, Kirchner JT. Intrauterine growth retardation. Am. Fam. Physician 1998; 58: 1384-90.
25. Mateev S, Sillau AH, Mouser R et al. Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: H820-9.
26. Chen CM, Wang LF, Lang YD. Effects of maternal undernutrition on lung growth and insulin-like growth factor system expression in rat offspring. Acta Paediatr. Taiwan 2007; 48: 62-7.
27. Dong F, Ford SP, Fang CX, Nijland MJ, Nathanielsz PW, Ren J. Maternal nutrient restriction during early to mid gestation up-regulates cardiac insulin-like growth factor (IGF) receptors associated with enlarged ventricular size in fetal sheep. Growth Horm. IGF Res. 2005; 15: 291-9.
28. Morrison JL. Sheep models of intrauterine growth restriction. Fetal adaptations and consequences. Clin. Exp. Pharmacol. Physiol. 2008; 35: 730-43.
29. Kramer MS. The epidemiology of adverse pregnancy outcomes: An overview. J. Nutr. 2003; 133 (Suppl.): S1592-6.
30. Dubiel M, Gudmundsson S, Gunnarsson G, Marsal K. Middle cerebral artery velocimetry as a predictor of hypoxemia in fetuses with increased resistance to blood flow in the umbilical artery. Early Hum. Dev. 1997; 47: 177-84.
31. Andersen LG, Angquist L, Eriksson JG et al. Birth weight, childhood body mass index and risk of coronary heart disease in adults: Combined historical cohort studies. PLoS ONE 2010; 5: e14126.
32. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298: 564-7.
33. Eriksson JG, Kajantie E, Thornburg KL, Osmond C, Barker DJ. Mother's body size and placental size predict coronary heart disease in men. Eur. Heart J. 2011; 32: 2297-303.
34. Richardson LJ, Hussey JM, Strutz KL. Origins of disparities in cardiovascular disease: Birth weight, body mass index, and young adult systolic blood pressure in the national longitudinal study of adolescent health. Ann. Epidemiol. 2011; 21: 598-607.
35. Rich-Edwards JW, Stampfer MJ, Manson JE et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since. BMJ 1976; 315: 396-400.
36. Leon DA, Lithell HO, Vâgerö D et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease. Cohort study of 15 000 Swedish men and women born 1915-29. BMJ 1998; 317: 241-5.
37. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989; 2: 577-80.
38. Zanardo V, Fanelli T, Weiner G et al. Intrauterine growth restriction is associated with persistent aortic wall thickening and glomerular proteinuria during infancy. Kidney Int. 2011; 80: 119-23.
39. Feldt K, Räikkönen K, Pyhälä R et al. Body size at birth and cardiovascular response to and recovery from mental stress in children. J. Hum. Hypertens. 2011; 25: 231-40.
40. Nicolaides KH, Economides DL, Soothill PW. Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses. Am. J. Obstet. Gynecol. 1989; 161: 996-1001.
41. Economides DL, Nicolaides KH. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am. J. Obstet. Gynecol. 1989; 160: 385-9.
42. Economides DL, Crook D, Nicolaides KH. Hypertriglyceridemia and hypoxemia in small-for-gestational-age fetuses. Am. J. Obstet. Gynecol. 1990; 162: 382-6.
43. Economides DL, Nicolaides KH, Campbell S. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J. Perinat. Med. 1991; 19: 97-105.
44. Botting KJ, Wang KC, Padhee M et al. Early origins of heart disease: Low birth weight and determinants of cardiomyocyte endowment. Clin. Exp. Pharmacol. Physiol. 2012; 39: 814-23.
45. Thornburg KL, Jonker SS, O'Tierney PO et al. Regulation of the cardiomyocyte population in the developing heart. Prog. Biophys. Mol. Biol. 2011; 106: 289-99.
46. Thornburg KL, Louey S. Fetal roots of cardiac disease. Heart 2005; 91: 867-8.
47. Porrello ER, Bell JR, Schertzer JD et al. Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009; 296: R672-80.
48. Porrello ER, Widdop RE, Delbridge LM. Early origins of cardiac hypertrophy: Does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart? Clin. Exp. Pharmacol. Physiol. 2008; 35: 1358-64.
49. Morrison JL, Botting KJ, Dyer JL, Williams SJ, Thornburg KL, McMillen IC. Restriction of placental function alters heart development in the sheep fetus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007; 293: R306-13.
50. Louey S, Jonker SS, Giraud G, Thornburg KL. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J. Physiol. 2007; 580: 639-48.
51. Bubb KJ, Cock ML, Black MJ et al. Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep. J. Physiol. 2007; 578: 871-81.
52. Corstius HB, Zimanyi MA, Maka N et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr. Res. 2005; 57: 796-800.
53. Danielson L, McMillen IC, Dyer JL, Morrison JL. Restriction of placental growth results in greater hypotensive response to alpha-adrenergic blockade in fetal sheep during late gestation. J. Physiol. 2005; 563: 611-20.
54. Edwards LJ, Simonetta G, Owens JA, Robinson JS, McMillen IC. Restriction of placental and fetal growth in sheep alters fetal blood pressure responses to angiotensin II and captopril. J. Physiol. 1999; 515: 897-904.
55. Louey S, Cock ML, Stevenson KM, Harding R. Placental insufficiency and fetal growth restriction lead to postnatal hypotension and altered postnatal growth in sheep. Pediatr. Res. 2000; 48: 808-14.
56. Barbera A, Giraud GD, Reller MD, Maylie J, Morton MJ, Thornburg KL. Right ventricular systolic pressure load alters myocyte maturation in fetal sheep. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 2000; 279: R1157-64.
57. Dyer JL, McMillen IC, Warnes KE, Morrison JL. No evidence for an enhanced role of endothelial nitric oxide in the maintenance of arterial blood pressure in the IUGR sheep fetus. Placenta 2009; 30: 705-10.
58. Duffield JA, Vuocolo T, Tellam R, Yuen BS, Muhlhausler BS, McMillen IC. Placental restriction of fetal growth decreases IGF1 and leptin mRNA expression in the perirenal adipose tissue of late gestation fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008; 294: R1413-19.
59. Giraud GD, Louey S, Jonker SS, Schultz J, Thornburg KL. Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus. Endocrinology 2006; 147: 3643-9.
60. Lumbers ER, Boyce AC, Joulianos G et al. Effects of cortisol on cardiac myocytes and on expression of cardiac genes in fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005; 288: R567-74.
61. Jackson JA, Wailoo MP, Thompson JR, Petersen SA. Early physiological development of infants with intrauterine growth retardation. Arch. Dis. Child. Fetal Neonatal Ed. 2004; 89: F46-50.
62. Simonetta G, Rourke AK, Owens JA, Robinson JS, McMillen IC. Impact of placental restriction on the development of the sympathoadrenal system. Pediatr. Res. 1997; 42: 805-11.
63. De Matteo R, Stacy V, Probyn M, Desai M, Ross M, Harding R. The perinatal development of arterial pressure in sheep: Effects of low birth weight due to twinning. Reprod. Sci. 2008; 15: 66-74.
64. Sundgren NC, Giraud GD, Schultz JM, Lasarev MR, Stork PJ, Thornburg KL. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003; 285: R1481-9.
65. Liu Y, Leri A, Li B et al. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circ. Res. 1998; 82: 1145-59.
66. Carter AM, Kingston MJ, Han KK, Mazzuca DM, Nygard K, Han VK. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs. J. Endocrinol. 2005; 184: 179-89.
67. Holzenberger M, Leneuve P, Hamard G et al. A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology 2000; 141: 2557-66.
68. Regnault TR, Friedman JE, Wilkening RB, Anthony RV, Hay WW. Fetoplacental transport and utilization of amino acids in IUGR: A review. Placenta 2005; 26: S52-62.
69. Jensen RB, Chellakooty M, Vielwerth S et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: Does insulin-like growth factor-I play a role? Horm. Res. 2003; 60: 136-48.
70. Reini SA, Wood CE, Keller-Wood M. The ontogeny of genes related to ovine fetal cardiac growth. Gene Expr. Patterns 2009; 9: 122-8.
71. Laustsen PG, Russell SJ, Cui L et al. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol. Cell. Biol. 2007; 27: 1649-64.
72. McMullen JR, Shioi T, Huang WY et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110 alpha) pathway. J. Biol. Chem. 2004; 279: 4782-93.
73. Kajstura J, Cheng W, Reiss K, Anversa P. The IGF-1-IGF-1 receptor system modulates myocyte proliferation but not myocyte cellular hypertrophy in vitro. Exp. Cell Res. 1994; 215: 273-83.
74. McMullen JR, Shioi T, Zhang L et al. Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol. Cell. Biol. 2004; 24: 6231-40.
75. Lavandero S, Foncea R, Pérez V, Sapag-Hagar M. Effect of inhibitors of signal transduction on IGF-1-induced protein synthesis associated with hypertrophy in cultured neonatal rat ventricular myocytes. FEBS Lett. 1998; 422: 193-6.
76. Shioi T, McMullen JR, Kang PM et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 2002; 22: 2799-809.
77. Shioi T, McMullen JR, Tarnavski O et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003; 107: 1664-70.
78. Lumbers ER, Kim MY, Burrell JH et al. Effects of intrafetal IGF-I on growth of cardiac myocytes in late-gestation fetal sheep. Am. J. Physiol. Endocrinol. Metab. 2009; 296: E513-19.
79. Powell K, Rooke JA, McEvoy TG et al. Zygote donor nitrogen metabolism and in vitro embryo culture perturbs in utero development and IGF2R expression in ovine fetal tissues. Theriogenology 2006; 66: 1901-12.
80. Pavelić J, Matijević T, Knezević J. Biological & physiological aspects of action of insulin-like growth factor peptide family. Indian J. Med. Res. 2007; 125: 511-22.
81. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu. Rev. Biochem. 1992; 61: 307-30.
82. Kirchhausen T. Single-handed recognition of a sorting traffic motif by the GGA proteins. Nat. Struct. Biol. 2002; 9: 241-4.
83. Chen Z, Ge Y, Kang JX. Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes. BMC Cell. Biol. 2004; 5: 15.
84. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 1994; 8: 2953-63.
85. Nolan CM, Lawlor MA. Variable accumulation of insulin-like growth factor II in mouse tissues deficient in insulin-like growth factor II receptor. Int. J. Biochem. Cell Biol. 1999; 31: 1421-33.
86. Koutsaki M, Sifakis S, Zaravinos A, Koutroulakis D, Koukoura O, Spandidos DA. Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm. IGF Res. 2011; 21: 31-6.
87. Abu-Amero SN, Ali Z, Bennet P, Vaughan J, Moore GE. Expression of the insulin-like growth factors and their receptors in term placentas. A comparison between normal and IUGR births. Mol. Reprod. Dev. 1998; 49: 229-35.
88. Börzsönyi B, Demendi C, Nagy Z et al. Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction. J. Perinat. Med. 2011; 39: 701-7.
89. Kind KL, Owens JA, Robinson JS, Quinn KJ, Grant PA, Walton PE. Effect of restriction of placental growth on expression of IGFs in fetal sheep: Relationship to fetal growth, circulating IGFs and binding proteins. J. Endocrinol. 1995; 146: 23-34.
90. Owens JA, Kind KL, Carbone F, Robinson JS, Owens PC. Circulating insulin-like growth factors-I and -II and substrates in fetal sheep following restriction of placental growth. J. Endocrinol. 1994; 140: 5-13.
91. Dong F, Ford SP, Nijland MJ, Nathanielsz PW, Ren J. Influence of maternal undernutrition and overfeeding on cardiac ciliary neurotrophic factor receptor and ventricular size in fetal sheep. J. Nutr. Biochem. 2008; 19: 409-14.
92. Olson AK, Protheroe KN, Scholz TD, Segar JL. The mitogen-activated protein kinases and Akt are developmentally regulated in the chronically anemic fetal sheep heart. J. Soc. Gynecol. Invest. 2006; 13: 157-65.
93. Huang CY, Buchanan DL, Gordon RL Jr et al. Increased insulin-like growth factor-I gene expression precedes left ventricular cardiomyocyte hypertrophy in a rapidly-hypertrophying rat model system. Cell Biochem. Funct. 2003; 21: 355-61.
94. Huang CY, Hao LY, Buetow DE. Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF-I receptor is IGF-II-dependent. Mol. Cell. Biochem. 2002; 233: 65-72.
95. Huang CY, Hao LY, Buetow DE. Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel-dependent. Mol. Cell. Biochem. 2002; 231: 51-9.
96. D'Angelo DD, Sakata Y, Lorenz JN et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc. Natl Acad. Sci. USA 1997; 94: 8121-6.
97. Filtz TM, Grubb DR, McLeod-Dryden TJ, Luo J, Woodcock EA. Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cβ1b. FASEB J. 2009; 23: 3564-70.
98. Dorn GW, Brown JH. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc. Med. 1999; 9: 26-34.
99. Chu CH, Tzang BS, Chen LM et al. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Gαq interaction and protein kinase C-α/CaMKII activation in H9c2 cardiomyoblast cells. J. Endocrinol. 2008; 197: 381-90.
100. Chen RJ, Wu HC, Chang MH et al. Leu27IGF2 plays an opposite role to IGF1 to induce H9c2 cardiomyoblast cell apoptosis via Gαq signaling. J. Mol. Endocrinol. 2009; 43: 221-30.
101. Chang MH, Kuo WW, Chen RJ et al. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells. J. Mol. Endocrinol. 2008; 41: 65-74.
102. Lee SD, Chu CH, Huang EJ et al. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am. J. Physiol. Endocrinol. Metab. 2006; 291: E306-14.
103. Chu CH, Lo JF, Hu WS et al. Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart. J. Cell. Physiol. 2012; 227: 259-68.
104. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: Linking early developmental environment to adult disease. Reprod. Toxicol. 2007; 23: 297-307.
105. Reik W, Constância M, Fowden A et al. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J. Physiol. 2003; 547: 35-44.
106. Young LE, Fernandes K, McEvoy TG et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat. Genet. 2001; 27: 153-4.
107. Zhang S, Rattanatray L, MacLaughlin SM et al. Periconceptional undernutrition in normal and overweight ewes leads to increased adrenal growth and epigenetic changes in adrenal IGF2/H19 gene in offspring. FASEB J. 2010; 24: 2772-82.
108. Ollikainen M, Smith KR, Joo EJ et al. DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Hum. Mol. Genet. 2010; 19: 4176-88.
109. Li CC, Maloney CA, Cropley JE, Suter CM. Epigenetic programming by maternal nutritions: Shaping future generations. Epigenomics 2010; 2: 539-49.
110. Bourque DK, Avila L, Penaherrera M, von Dadelszen P, Robinson WP. Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia. Placenta 2010; 31: 197-202.
111. Koukoura O, Sifakis S, Zaravinos A et al. Hypomethylation along with increased H19 expression in placentas from pregnancies complicated with fetal growth restriction. Placenta 2011; 32: 51-7.
112. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, Greally JM. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J. Biol. Chem. 2010; 285: 15111-18.
113. Einstein F, Thompson RF, Bhagat TD et al. Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS ONE 2010; 5: e8887.
114. Ptak C, Petronis A. Epigenetics and complex disease: From etiology to new therapeutics. Annu. Rev. Pharmacol. Toxicol. 2008; 48: 257-76.
115. Slater-Jefferies JL, Lillycrop KA, Townsend PA et al. Feeding a protein-restricted diet during pregnancy induces altered epigenetic regulation of peroxisomal proliferator-activated receptor-α in the heart of the offspring. J. Dev. Orig. Health Dis. 2011; 2: 250-5.
116. Patterson AJ, Chen M, Xue Q, Xiao D, Zhang L. Chronic prenatal hypoxia induces epigenetic programming of PKCε gene repression in rat hearts. Circ. Res. 2010; 107: 365-73.
117. Xue Q, Dasgupta C, Chen M, Zhang L. Foetal hypoxia increases cardiac AT(2)R. Expression and subsequent vulnerability to adult ischaemic injury. Cardiovasc. Res. 2011; 89: 300-8.